Biocon Limited — Board Meeting, 08-05-2025: Outcome of Board Meeting

Biocon has announced a board meeting on May 8, 2025, approving the financial results for the quarter and year ended March 31, 2025. Consolidated revenues were Rs. 16,470 Cr with a net profit of Rs. 1,429 Cr, showing steady growth. The board approved a final dividend of Rs. 0.50 per share. Operationally, the company gained from selling certain business units and refinanced its major biosimilars acquisition, boosting liquidity. Ms. Naina Lal Kidwai is proposed for re-appointment as Independent Director, along with a five-year term secretarial auditor appointment, both pending shareholder approval.